DSM Venturing and Strategic Health Investment Partners extended the Stanford cartilage replacement spinout's series A round, augmenting a $16m first close featuring Johnson & Johnson and Osage University Partners.
Hyalex Orthopaedics, a US-based cartilage replacement material spinout of Stanford University, increased its series A round from $16m to $33m yesterday.
The additional funding came from investors including DSM Venturing, the open innovation arm of health, nutrition and material product supplier DSM, and medical device-focused venture capital firm Strategic Health Investment Partners.
The new funding followed an initial $16m series A tranche in June 2017 led by VC firm Canaan Partners and backed by Johnson & Johnson…
